ANI Pharmaceuticals
Price & Volume
Stats
See more52W Range | $52.50-$70.48 |
Market Cap | $1.4B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $614.3M |
Revenue Growth (YoY) | 44.8% |
Gross Profit (12 Mos) | $364.1M |
Diluted EPS | -$1.04 |
News
See moreYahoo Finance • 24 days ago
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
Yahoo Finance • last month
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
Yahoo Finance • last month
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®
Yahoo Finance • last month
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
About
CEO | Mr. Nikhil Lalwani |
CFO | Mr. Stephen P. Carey |
Address | 210 Main Street West, Baudette, MN, United States, 56623 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 897 |
